Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Fludarabine plus cyclophosphamide for the treatment of CLL

Aug. 1, 2007

Eisai to begin trial to determine MTD of E-7107 in cancer patients

Aug. 1, 2007

Regulatory update on satraplatin

Aug. 1, 2007

Threshold begins phase I trial of TH-302 for solid tumors

Aug. 1, 2007

Symposium features Sirtex's SIR-Spheres for colorectal liver metastases

Aug. 1, 2007

ImClone and Bristol-Myers expand Erbitux codevelopment agreement

July 31, 2007

Osiris and Genzyme to codevelop Prochymal for ARS

July 31, 2007

Patient treatment begins in phase I/II trial of MDV-3100 in hormone-refractory prostate cancer

July 30, 2007

Cell Therapeutics acquires Systems Medicine; gains worldwide rights to brostallicin

July 27, 2007

ODAC recommends FDA waits for survival results of phase III satraplatin trial

July 27, 2007

Popular Stories

Today's news in brief
BioWorld
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...